Australia · Delayed Price · Currency is AUD Theseus Pharmaceuticals Statistics
Total Valuation
Ansell has a market cap or net worth of AUD 4.35 billion. The enterprise value is 5.27 billion.
| Market Cap | 4.35B |
| Enterprise Value | 5.27B |
Important Dates
The next estimated earnings date is Monday, August 25, 2025.
| Earnings Date | Aug 25, 2025 |
| Ex-Dividend Date | Feb 14, 2025 |
Share Statistics
Ansell has 144.82 million shares outstanding. The number of shares has increased by 10.20% in one year.
| Current Share Class | 144.82M |
| Shares Outstanding | 144.82M |
| Shares Change (YoY) | +10.20% |
| Shares Change (QoQ) | +9.78% |
| Owned by Insiders (%) | 0.46% |
| Owned by Institutions (%) | 54.89% |
| Float | 143.47M |
Valuation Ratios
The trailing PE ratio is 23.10 and the forward PE ratio is 14.95. Ansell's PEG ratio is 1.67.
| PE Ratio | 23.10 |
| Forward PE | 14.95 |
| PS Ratio | 1.45 |
| PB Ratio | 1.40 |
| P/TBV Ratio | 10.05 |
| P/FCF Ratio | 12.33 |
| P/OCF Ratio | 9.92 |
| PEG Ratio | 1.67 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.36, with an EV/FCF ratio of 14.96.
| EV / Earnings | 29.11 |
| EV / Sales | 1.76 |
| EV / EBITDA | 10.36 |
| EV / EBIT | 13.34 |
| EV / FCF | 14.96 |
Financial Position
The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.43.
| Current Ratio | 2.31 |
| Quick Ratio | 1.03 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | 2.62 |
| Debt / FCF | 3.78 |
| Interest Coverage | 7.37 |
Financial Efficiency
Return on equity (ROE) is 6.48% and return on invested capital (ROIC) is 6.32%.
| Return on Equity (ROE) | 6.48% |
| Return on Assets (ROA) | 5.28% |
| Return on Invested Capital (ROIC) | 6.32% |
| Return on Capital Employed (ROCE) | 8.69% |
| Revenue Per Employee | 199,736 |
| Profits Per Employee | 12,076 |
| Employee Count | 15,000 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 2.22 |
Taxes
In the past 12 months, Ansell has paid 69.48 million in taxes.
| Income Tax | 69.48M |
| Effective Tax Rate | 27.44% |
Stock Price Statistics
The stock price has increased by +9.65% in the last 52 weeks. The beta is 0.33, so Ansell's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +9.65% |
| 50-Day Moving Average | 30.72 |
| 200-Day Moving Average | 32.40 |
| Relative Strength Index (RSI) | 41.36 |
| Average Volume (20 Days) | 276,195 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ansell had revenue of AUD 3.00 billion and earned 181.14 million in profits. Earnings per share was 1.30.
| Revenue | 3.00B |
| Gross Profit | 1.17B |
| Operating Income | 395.41M |
| Pretax Income | 253.21M |
| Net Income | 181.14M |
| EBITDA | 471.52M |
| EBIT | 395.41M |
| Earnings Per Share (EPS) | 1.30 |
Balance Sheet
The company has 434.52 million in cash and 1.33 billion in debt, giving a net cash position of -899.73 million or -6.21 per share.
| Cash & Cash Equivalents | 434.52M |
| Total Debt | 1.33B |
| Net Cash | -899.73M |
| Net Cash Per Share | -6.21 |
| Equity (Book Value) | 3.11B |
| Book Value Per Share | 21.18 |
| Working Capital | 971.96M |
Cash Flow
In the last 12 months, operating cash flow was 438.23 million and capital expenditures -85.64 million, giving a free cash flow of 352.59 million.
| Operating Cash Flow | 438.23M |
| Capital Expenditures | -85.64M |
| Free Cash Flow | 352.59M |
| FCF Per Share | 2.43 |
Margins
Gross margin is 39.10%, with operating and profit margins of 13.20% and 6.05%.
| Gross Margin | 39.10% |
| Operating Margin | 13.20% |
| Pretax Margin | 8.45% |
| Profit Margin | 6.05% |
| EBITDA Margin | 15.74% |
| EBIT Margin | 13.20% |
| FCF Margin | 11.77% |
Dividends & Yields
This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 1.99%.
| Dividend Per Share | 0.60 |
| Dividend Yield | 1.99% |
| Dividend Growth (YoY) | 2.46% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 46.74% |
| Buyback Yield | -10.20% |
| Shareholder Yield | -8.20% |
| Earnings Yield | 4.17% |
| FCF Yield | 8.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 15, 2002. It was a reverse split with a ratio of 0.2.
| Last Split Date | Apr 15, 2002 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
Ansell has an Altman Z-Score of 2.63 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.63 |
| Piotroski F-Score | 7 |